Naqi Haider

Company: Prime Medicine

Job title: Head of Stem Cell Biology

Seminars:

Integrative Approaches for Prime Editing Drug Discovery Across Diseases Indications Using iPSC-Derived Model Systems 11:45 am

Prime Editing enables precise correction of upwards of 90% of all human pathogenic mutations. Prime Editing’s ability to precisely make large & small edits, insertions, and deletions without double strand breaks represents a potential curative approach for patients To advance the development of Prime Editing therapies we have established robust physiologically relevant high-throughput in vitro…Read more

day: Day Two Track A AM